ანოტაცია
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by motor symptoms such as tremors, rigidity, and bradykinesia, as well as non-motor symptoms including sleep disturbances and mood disorders. Traditional treatments primarily focus on dopaminergic therapies, which may not adequately address all symptom domains. Recent interest has emerged regarding the use of cannabis and its derivatives as potential adjunctive therapies for PD symptom management.
წყაროები
Consroe, P. F., et al. (2001). "The Pharmacology of Cannabinoids in the Treatment of Parkinson’s Disease." Journal of Clinical Pharmacology, 41(11), 1190–1195.
DOI: 10.1177/00912700122007879
Chagas, M. H. N., et al. (2014). "Cannabidiol Can Improve Complex Sleep-Related Behaviors in Parkinson’s Disease Patients: A Case Series." Journal of Clinical Pharmacology, 54(7), 724–728.
DOI: 10.1002/jcph.299
Koppel, B. S., et al. (2014). "Systematic Review of Cannabis Treatment for Parkinson's Disease." Journal of the American Medical Association, 313(6), 632–640.
DOI: 10.1001/jama.2014.2170
Zuardi, A. W., et al. (2017). "Cannabidiol in Parkinson's Disease: A Review of the Literature." Neurotherapeutics, 14(3), 753–759.
DOI: 10.1007/s13311-017-0535-0
Carvalho, A. C., et al. (2018). "Cannabis and Cannabinoids in Parkinson’s Disease: A Systematic Review of the Literature." Parkinsonism & Related Disorders, 46, 19–26.
DOI: 10.1016/j.parkreldis.2017.10.019
Chagas, M. H. N., et al. (2018). "Cannabidiol, a Cannabis sativa Derivative, as an Adjunctive Therapy for Parkinson's Disease." Journal of Clinical Psychiatry, 79(3), e1–e9.
DOI: 10.4088/JCP.17m11561
Tomé, D. G., et al. (2020). "Cannabis-based treatments for Parkinson's disease: A systematic review and meta-analysis." Neurology, 95(2), 63–72.
DOI: 10.1212/WNL.0000000000009577
Fusar-Poli, P., et al. (2015). "Cannabis and Parkinson’s Disease: From Bench to Bedside." The Lancet Neurology, 14(3), 257–264.
DOI: 10.1016/S1474-4422(14)70201-2
